
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Circular RNA circ-MMP11 Contributes to Lapatinib Resistance of Breast Cancer Cells by Regulating the miR-153-3p/ANLN Axis
Xiaoli Wu, Yi Ren, Rong Yao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 47
Xiaoli Wu, Yi Ren, Rong Yao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 47
Showing 1-25 of 47 citing articles:
Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 101
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 101
Circular RNAs in breast cancer diagnosis, treatment and prognosis
X. Huang, Cailu Song, JINHUI ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 2, pp. 241-249
Open Access | Times Cited: 57
X. Huang, Cailu Song, JINHUI ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 2, pp. 241-249
Open Access | Times Cited: 57
Exosomal circRNAs in cancer: Implications for therapy resistance and biomarkers
Zhengjun Lin, Yuqiao Ji, Jian Zhou, et al.
Cancer Letters (2023) Vol. 566, pp. 216245-216245
Closed Access | Times Cited: 37
Zhengjun Lin, Yuqiao Ji, Jian Zhou, et al.
Cancer Letters (2023) Vol. 566, pp. 216245-216245
Closed Access | Times Cited: 37
The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
Malihe Rezaee, Fatemeh Mohammadi, Atoosa Keshavarzmotamed, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 32
Malihe Rezaee, Fatemeh Mohammadi, Atoosa Keshavarzmotamed, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 32
Recent advances of exosomal circRNAs in cancer and their potential clinical applications
Qian Yi, Jiaji Yue, Yang Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Qian Yi, Jiaji Yue, Yang Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance
Anastasia N. Kazakova, Maria M. Lukina, Ksenia S. Anufrieva, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 8
Anastasia N. Kazakova, Maria M. Lukina, Ksenia S. Anufrieva, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 8
Exosomal circular RNAs: New player in breast cancer progression and therapeutic targets
Bashdar Mahmud Hussen, Sayran Mohamadtahr, Snur Rasool Abdullah, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 17
Bashdar Mahmud Hussen, Sayran Mohamadtahr, Snur Rasool Abdullah, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 17
New insights into the potential of exosomal circular RNAs in mediating cancer chemotherapy resistance and their clinical applications
Qiang Li, Yuhao Zhang, Peikan Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117027-117027
Open Access | Times Cited: 6
Qiang Li, Yuhao Zhang, Peikan Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117027-117027
Open Access | Times Cited: 6
The Role of Circular RNAs in the Drug Resistance of Cancers
Xinyuan Liu, Qi Zhang, Jing Guo, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 25
Xinyuan Liu, Qi Zhang, Jing Guo, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 25
Circular RNAs: biology and clinical significance of breast cancer
Zhanwei Wang, Hao Deng, Jin Yao, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 859-874
Open Access | Times Cited: 15
Zhanwei Wang, Hao Deng, Jin Yao, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 859-874
Open Access | Times Cited: 15
The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications
Mark Samuels, William Jones, Benjamin P. Towler, et al.
Oncogene (2023) Vol. 42, Iss. 41, pp. 3017-3034
Open Access | Times Cited: 14
Mark Samuels, William Jones, Benjamin P. Towler, et al.
Oncogene (2023) Vol. 42, Iss. 41, pp. 3017-3034
Open Access | Times Cited: 14
Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA
Simin Ye, Shiyu Chen, Xiaoyan Yang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Simin Ye, Shiyu Chen, Xiaoyan Yang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Exosomes: a significant medium for regulating drug resistance through cargo delivery
Bixuan Ren, Xiaoqing Li, Zhihua Zhang, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 4
Bixuan Ren, Xiaoqing Li, Zhihua Zhang, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 4
Circular RNAs as Key Regulators in Cancer Hallmarks: New Progress and Therapeutic Opportunities
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Rohana Jaafar, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104612-104612
Open Access
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Rohana Jaafar, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104612-104612
Open Access
Extracellular Vesicles as Mediators and Potential Targets in Combating Cancer Drug Resistance
Haodong Zhang, Bohan Wu, Y. N. Wang, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 498-498
Open Access
Haodong Zhang, Bohan Wu, Y. N. Wang, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 498-498
Open Access
Evaluation of the role of circular RNA (circ-FAF1) as a diagnostic biomarker for breast cancer in a cohort of Egyptian breast cancer patients
Eman Mohamed Abdellatif, Neamat Hegazy, Eman Saad Nassar
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Eman Mohamed Abdellatif, Neamat Hegazy, Eman Saad Nassar
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
CircMMP11 is a Potential Recurrence Biomarker and Facilitates Progression of Esophageal Squamous Cell Carcinoma
Jingnan Yuan, Ying Cui, Jing Zhang, et al.
Biochemical Genetics (2025)
Closed Access
Jingnan Yuan, Ying Cui, Jing Zhang, et al.
Biochemical Genetics (2025)
Closed Access
Emerging role and clinical applications of circular RNAs in human diseases
Subhayan Sur, Jayanta K. Pal, Shashank Shekhar, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Subhayan Sur, Jayanta K. Pal, Shashank Shekhar, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Exosomal circRNAs: key modulators in breast cancer progression
Guozhen Liu, Quan Liu, Lingmei Jia, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Guozhen Liu, Quan Liu, Lingmei Jia, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Circular RNA and its potential diagnostic and therapeutic values in breast cancer
Di Gao, Can Cui, Yaoxuan Jiao, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Di Gao, Can Cui, Yaoxuan Jiao, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Exosomal miR92a Promotes Cytarabine Resistance in Myelodysplastic Syndromes by Activating Wnt/β-catenin Signal Pathway
Hongjiao Li, Chenglian Xie, Yurong Lu, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1448-1448
Open Access | Times Cited: 13
Hongjiao Li, Chenglian Xie, Yurong Lu, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1448-1448
Open Access | Times Cited: 13
Novel Insights into Circular RNAs in Metastasis in Breast Cancer: An Update
Paola Zepeda-Enríquez, Macrina B. Silva-Cázares, César López‐Camarillo
Non-Coding RNA (2023) Vol. 9, Iss. 5, pp. 55-55
Open Access | Times Cited: 7
Paola Zepeda-Enríquez, Macrina B. Silva-Cázares, César López‐Camarillo
Non-Coding RNA (2023) Vol. 9, Iss. 5, pp. 55-55
Open Access | Times Cited: 7
Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1)
Yue Yang, Longqing Shi, Dong Zhang, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 6713-6723
Open Access | Times Cited: 16
Yue Yang, Longqing Shi, Dong Zhang, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 6713-6723
Open Access | Times Cited: 16
Circular RNAs in Breast Cancer: An Update
Haolin Bao, Jiehan Li, Qihang Zhao, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 158-158
Open Access | Times Cited: 2
Haolin Bao, Jiehan Li, Qihang Zhao, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 158-158
Open Access | Times Cited: 2
circRNAs in drug resistance of breast cancer
Sema Mısır, SERAP OZER YAMAN, Nina Petrović, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2022) Vol. 30, Iss. 4, pp. 157-172
Open Access | Times Cited: 11
Sema Mısır, SERAP OZER YAMAN, Nina Petrović, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2022) Vol. 30, Iss. 4, pp. 157-172
Open Access | Times Cited: 11